Cargando…

A systematic review and meta-analysis of cold exposure and cardiovascular disease outcomes

BACKGROUND: Cold exposure has been considered an essential risk factor for the global disease burden, while its role in cardiovascular diseases is still underappreciated. The increase in frequency and duration of extreme cold weather events like cold spells makes it an urgent task to evaluate the ef...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fan, Jie-Fu, Xiao, Yu-Chen, Feng, Yi-Fei, Niu, Lu-Yu, Tan, Xing, Sun, Jia-Cen, Leng, Yue-Qi, Li, Wan-Yang, Wang, Wei-Zhong, Wang, Yang-Kai
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Cardiovascular Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10083291/ https://www.ncbi.nlm.nih.gov/pubmed/37051068 http://dx.doi.org/10.3389/fcvm.2023.1084611

Ejemplares similares

DPP3: From biomarker to therapeutic target of cardiovascular diseases
por: Ye, Peng, et al.
Publicado: (2022)

Histone modification of endothelial-mesenchymal transition in cardiovascular diseases
por: Jun, Qiu, et al.
Publicado: (2022)

Editorial: Highlights for Cardiovascular Therapeutics in 2021 – Trained Immunity, Immunometabolism, Gender Differences of Cardiovascular Diseases, and Novel Targets of Cardiovascular Therapeutics
por: Yang, William Y., et al.
Publicado: (2022)

Immune heterogeneity in cardiovascular diseases from a single-cell perspective
por: Su, Xin, et al.
Publicado: (2023)

Prognostic performance of multiple biomarkers in patients with acute coronary syndrome without standard cardiovascular risk factors
por: Wang, Le, et al.
Publicado: (2022)

Corrigendum: Immune heterogeneity in cardiovascular diseases from a single-cell perspective
por: Su, Xin, et al.
Publicado: (2023)

Cold Pressor Test in Primary Hypertension: A Cross-Sectional Study
por: Han, Yue, et al.
Publicado: (2022)

The role of m5C methyltransferases in cardiovascular diseases
por: Wang, Yan-Yue, et al.
Publicado: (2023)

Editorial: Insights in cardiovascular therapeutics: 2021 – cell death, cardiovascular injuries, and novel targets of cardiovascular therapeutics
por: Xu, Keman, et al.
Publicado: (2022)

Epicardial fat volume, an independent risk factor for major adverse cardiovascular events, had an incremental prognostic value to myocardial perfusion imaging in Chinese populations with suspected or known coronary artery disease with a normal left ventricular ejection fraction
por: Yang, Le, et al.
Publicado: (2023)

Wildfire smoke exposure and cardiovascular disease—should statins be recommended to prevent cardiovascular events?
por: Vuorio, Alpo, et al.
Publicado: (2023)

Endocan: A Key Player of Cardiovascular Disease
por: Chen, Jinzhi, et al.
Publicado: (2022)

Ideal Cardiovascular Health Metrics Modify the Association Between Exposure to Chinese Famine in Fetal and Cardiovascular Disease: A Prospective Cohort Study
por: Ding, Xiong, et al.
Publicado: (2021)

Optimal Strategy for Antiplatelet Therapy After Coronary Drug-Eluting Stent Implantation in High-Risk “TWILIGHT-like” Patients With Diabetes Mellitus
por: Wang, Hao-Yu, et al.
Publicado: (2020)

CircHIPK3 Plays Vital Roles in Cardiovascular Disease
por: Zhang, Lei, et al.
Publicado: (2021)

Clinical and hemodynamic features of acute pulmonary embolism patients diagnosed in cold weather predicts adverse clinical outcome
por: Sun, Na, et al.
Publicado: (2022)

The Usefulness of C-Reactive Protein to Albumin Ratio in the Prediction of Adverse Cardiovascular Events in Coronary Chronic Total Occlusion Undergoing Percutaneous Coronary Intervention
por: Cheng, Lele, et al.
Publicado: (2021)

The Role of Ferroptosis in Cardiovascular Disease and Its Therapeutic Significance
por: Chen, Zhenzhen, et al.
Publicado: (2021)

Gaming Instead of Training? Exergaming Induces High-Intensity Exercise Stimulus and Reduces Cardiovascular Reactivity to Cold Pressor Test
por: Ketelhut, Sascha, et al.
Publicado: (2022)

Effect of alirocumab and evolocumab on all-cause mortality and major cardiovascular events: A meta-analysis focusing on the number needed to treat
por: Wang, Hong-Fei, et al.
Publicado: (2022)

Association between radiotherapy and risk of death from cardiovascular diseases in lung and bronchus cancer
por: Yi, Zhong, et al.
Publicado: (2023)

Case report: Aortoesophageal fistula—an extremely rare but life-threatening cardiovascular cause of hematemesis
por: Wong, Alexis Ching, et al.
Publicado: (2023)

Pyroptosis: Role and Mechanisms in Cardiovascular Disease
por: Chen, Xinzhe, et al.
Publicado: (2022)

The optimal pulse pressures for healthy adults with different ages and sexes correlate with cardiovascular health metrics
por: Chou, Chung-Hsing, et al.
Publicado: (2022)

Pneumonia After Cardiovascular Surgery: Incidence, Risk Factors and Interventions
por: Wang, Dashuai, et al.
Publicado: (2022)

A Prospective Study of Grip Strength Trajectories and Incident Cardiovascular Disease
por: Liu, Weida, et al.
Publicado: (2021)

Cardiovascular Impairment in COVID-19: Learning From Current Options for Cardiovascular Anti-Inflammatory Therapy
por: Wang, Lun, et al.
Publicado: (2020)

Effect of Exercise Prescription Implementation Rate on Cardiovascular Events
por: Zhu, Li-Yue, et al.
Publicado: (2022)

Cardiovascular Changes in Patients With COVID-19 From Wuhan, China
por: Song, Limin, et al.
Publicado: (2020)

Insights Into Platelet-Derived MicroRNAs in Cardiovascular and Oncologic Diseases: Potential Predictor and Therapeutic Target
por: Leng, Qianru, et al.
Publicado: (2022)

Editorial: Insights in cardiovascular therapeutics 2022—cardiovascular innate immunity
por: Xu, Keman, et al.
Publicado: (2023)

The underlying pathological mechanism of ferroptosis in the development of cardiovascular disease
por: Zhang, Li-Li, et al.
Publicado: (2022)

Negative Risk Markers for Cardiovascular Risk Evaluation in Chinese Adults
por: Bie, Lizhan, et al.
Publicado: (2022)

Experimental Rodent Models of Cardiovascular Diseases
por: Jia, Tian, et al.
Publicado: (2020)

Editorial: Metabolic regulation in cardiovascular homeostasis and disease
por: Song, Kunhua, et al.
Publicado: (2022)

Paeonol for the Treatment of Atherosclerotic Cardiovascular Disease: A Pharmacological and Mechanistic Overview
por: Wu, Min, et al.
Publicado: (2021)

Prevalence and Predictors of Left Ventricular Diastolic Dysfunction in Malaysian Patients With Type 2 Diabetes Mellitus Without Prior Known Cardiovascular Disease
por: Chee, Kok Han, et al.
Publicado: (2021)

The Role of Interleukin-6 Family Members in Cardiovascular Diseases
por: Feng, Yongqi, et al.
Publicado: (2022)

The influence of testosterone on the risk of cardiovascular events after percutaneous coronary intervention
por: Chiang, Cheng-Hung, et al.
Publicado: (2022)

Editorial: New mechanisms and drugs for the treatment of cardiovascular disease with diabetes
por: Zhang, Shanshan, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_84ai6podavdu71ddv96fm8lqn9